Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 31% ± 10% | |
endothelial cell | 8 studies | 29% ± 10% | |
glutamatergic neuron | 8 studies | 41% ± 27% | |
microglial cell | 8 studies | 25% ± 8% | |
adipocyte | 8 studies | 22% ± 5% | |
astrocyte | 8 studies | 30% ± 12% | |
retinal cone cell | 7 studies | 27% ± 5% | |
GABAergic neuron | 7 studies | 40% ± 22% | |
oligodendrocyte precursor cell | 7 studies | 26% ± 11% | |
interneuron | 6 studies | 36% ± 24% | |
epithelial cell | 6 studies | 33% ± 11% | |
dendritic cell | 5 studies | 21% ± 7% | |
macrophage | 5 studies | 24% ± 6% | |
cardiac muscle cell | 4 studies | 18% ± 1% | |
fibroblast | 4 studies | 24% ± 6% | |
ciliated cell | 4 studies | 21% ± 5% | |
retinal rod cell | 4 studies | 24% ± 9% | |
smooth muscle cell | 4 studies | 18% ± 2% | |
neuron | 3 studies | 31% ± 13% | |
GABAergic interneuron | 3 studies | 20% ± 3% | |
retinal pigment epithelial cell | 3 studies | 38% ± 16% | |
club cell | 3 studies | 22% ± 9% | |
endothelial cell of lymphatic vessel | 3 studies | 25% ± 8% | |
monocyte | 3 studies | 18% ± 3% | |
pericyte | 3 studies | 24% ± 7% | |
basal cell | 3 studies | 34% ± 18% | |
transit amplifying cell | 3 studies | 33% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 2166.29 | 21 / 21 | 100% | 12.15 | 504 / 504 |
esophagus | 100% | 1948.58 | 1445 / 1445 | 100% | 16.55 | 183 / 183 |
breast | 100% | 2448.83 | 459 / 459 | 100% | 13.33 | 1117 / 1118 |
lung | 100% | 2030.50 | 577 / 578 | 100% | 12.04 | 1154 / 1155 |
prostate | 100% | 2009.19 | 245 / 245 | 100% | 9.61 | 500 / 502 |
ovary | 100% | 2369.04 | 180 / 180 | 100% | 8.50 | 428 / 430 |
intestine | 100% | 2006.35 | 966 / 966 | 99% | 11.46 | 524 / 527 |
uterus | 100% | 2294.31 | 170 / 170 | 99% | 10.85 | 456 / 459 |
brain | 99% | 1709.97 | 2611 / 2642 | 100% | 9.76 | 704 / 705 |
thymus | 100% | 2103.13 | 653 / 653 | 98% | 7.33 | 595 / 605 |
pancreas | 100% | 1359.49 | 328 / 328 | 98% | 8.16 | 175 / 178 |
stomach | 100% | 1401.19 | 359 / 359 | 98% | 12.04 | 281 / 286 |
kidney | 100% | 1181.15 | 89 / 89 | 96% | 7.77 | 869 / 901 |
skin | 100% | 2933.23 | 1809 / 1809 | 96% | 10.24 | 453 / 472 |
adrenal gland | 100% | 1979.63 | 258 / 258 | 95% | 6.29 | 219 / 230 |
liver | 100% | 1010.28 | 226 / 226 | 85% | 4.19 | 346 / 406 |
adipose | 100% | 2153.63 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.46 | 29 / 29 |
muscle | 100% | 2895.87 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1779.64 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.37 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.30 | 1 / 1 |
blood vessel | 100% | 1556.52 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 1248.69 | 816 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 83% | 5.00 | 66 / 80 |
peripheral blood | 41% | 992.73 | 383 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0017196 | Biological process | N-terminal peptidyl-methionine acetylation |
GO_0031416 | Cellular component | NatB complex |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | NAA25 |
Protein name | N-alpha-acetyltransferase 25, NatB auxiliary subunit N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120) |
Synonyms | C12orf30 MDM20 NAP1 |
Description | FUNCTION: Non-catalytic subunit of the NatB complex which catalyzes acetylation of the N-terminal methionine residues of peptides beginning with Met-Asp, Met-Glu, Met-Asn and Met-Gln. May play a role in normal cell-cycle progression. . |
Accessions | F8VSB9 ENST00000261745.9 [Q14CX7-1] ENST00000549711.5 H0YHR9 ENST00000551858.1 ENST00000547133.1 F8W0N5 Q14CX7 |